AES Endorsement: Intracranial Neuromodulation for Pediatric Drug-Resistant Epilepsy

To influence the AMA’s advocacy agenda and ensure that epilepsy-related concerns are prioritized, AES must secure a seat in the House of Delegates.

The CDC Epilepsy Program has been a vital resource for both people with epilepsy and epilepsy professionals for decades.

AES reaffirms its unwavering commitment to advancing health equity for people with epilepsy and fostering an inclusive environment for epilepsy professionals.

AES strongly opposes the proposed funding cuts to the NIH, including the drastic reduction of indirect/F&A cost reimbursements to a 15% cap.

We are pleased to announce the implementation of a new physician specialty code-F6, used to indicate the specialty designation for an epileptologist.

AES invites steering committee to lead community-wide consensus process to draft a nat'l plan for epilepsy, incorporating input from all stakeholders.

Information for clinicians after a safety warning for patients with underlying cardiac disorders/arrhythmias to the PI for lamotrigine.

The AES Board has created a committee dedicated to accelerating diversity, equity, and inclusion in our Society's work.